Skip to main content
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1973;71:233–242.

New antifungal therapy in ophthalmology.

T W Lieberman, I H Leopold
PMCID: PMC1310493  PMID: 10949601

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen H. F. Amphotericin B and exogenous mycotic endophthalmitis after cataract extraction. Arch Ophthalmol. 1972 Dec;88(6):640–644. doi: 10.1001/archopht.1972.01000030642014. [DOI] [PubMed] [Google Scholar]
  2. Buckley R. H., Lucas Z. J., Hattler B. G., Jr, Zmijewski C. M., Amos D. B. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol. 1968 Feb;3(2):153–169. [PMC free article] [PubMed] [Google Scholar]
  3. Burgess M. A., Bodey G. P. Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrob Agents Chemother. 1972 Dec;2(6):423–426. doi: 10.1128/aac.2.6.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Butler W. T. Pharmacology, toxicity, and therapeutic usefulness of amphotericin B. JAMA. 1966 Jan 31;195(5):371–375. [PubMed] [Google Scholar]
  5. Dikstein S. Antifungal drugs for oculomycosis. 3. In vitro measurement of corneal endothelial toxicity of certain antifungal drugs. Trans Ophthalmol Soc U K. 1970;89:845–846. [PubMed] [Google Scholar]
  6. Ellison A. C., Newmark E., Kaufman H. E. Chemotherapy of experimental keratomycosis. Am J Ophthalmol. 1969 Nov;68(5):812–819. doi: 10.1016/0002-9394(69)94573-5. [DOI] [PubMed] [Google Scholar]
  7. Fishman L. S., Griffin J. R., Sapico F. L., Hecht R. Hematogenous Candida endophthalmitis--a complication of candidemia. N Engl J Med. 1972 Mar 30;286(13):675–681. doi: 10.1056/NEJM197203302861301. [DOI] [PubMed] [Google Scholar]
  8. GOTTLIEB D., CARTER H. E., SLONEKER J. H., AMMANN A. Protection of fungi against polyene antibiotics by sterols. Science. 1958 Aug 15;128(3320):361–361. doi: 10.1126/science.128.3320.361. [DOI] [PubMed] [Google Scholar]
  9. Greene W. H., Wiernik P. H. Candida endophthalmitis. Successful treatment in a patient with acute leukemia. Am J Ophthalmol. 1972 Dec;74(6):1100–1104. [PubMed] [Google Scholar]
  10. Jones D. B., Sexton R., Rebell G. Mycotic keratitis in South Florida: a review of thirty-nine cases. Trans Ophthalmol Soc U K. 1970;89:781–797. [PubMed] [Google Scholar]
  11. KINSKY S. C. Nystatin binding by protoplasts and a particulate fraction of Neurospora crassa, and a basis for the selective toxicity of polyene antifungal antibiotics. Proc Natl Acad Sci U S A. 1962 Jun 15;48:1049–1056. doi: 10.1073/pnas.48.6.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Keim G. R., Jr, Poutsiaka J. W., Kirpan J., Keysser C. H. Amphotericin B methyl ester hydrochloride and amphotericin B: comparative acute toxicity. Science. 1973 Feb 9;179(4073):584–585. doi: 10.1126/science.179.4073.584. [DOI] [PubMed] [Google Scholar]
  13. Kinsky S. C. Antibiotic interaction with model membranes. Annu Rev Pharmacol. 1970;10:119–142. doi: 10.1146/annurev.pa.10.040170.001003. [DOI] [PubMed] [Google Scholar]
  14. Kirkpatrick C. H., Chandler J. W., Schimke R. N. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol. 1970 Mar;6(3):375–385. [PMC free article] [PubMed] [Google Scholar]
  15. Kirkpatrick C. H., Rich R. R., Graw R. G., Jr, Smith T. K., Mickenberg I., Rogentine G. N. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution. Clin Exp Immunol. 1971 Dec;9(6):733–748. [PMC free article] [PubMed] [Google Scholar]
  16. Kobbayashi G. S., Medoff G., Schlessinger D., Kwan C. N., Musser W. E. Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. Science. 1972 Aug 25;177(4050):709–710. doi: 10.1126/science.177.4050.709. [DOI] [PubMed] [Google Scholar]
  17. Kwan C. N., Medoff G., Kobayashi G. S., Schlessinger D., Raskas H. J. Potentiation of the antifungal effects of antibiotics by amphotericin B. Antimicrob Agents Chemother. 1972 Aug;2(2):61–65. doi: 10.1128/aac.2.2.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LEY A. P. Experimental fungus infections of the cornea; a preliminary report. Am J Ophthalmol. 1956 Oct;42(4 Pt 2):59–71. doi: 10.1016/0002-9394(56)90356-7. [DOI] [PubMed] [Google Scholar]
  19. Medoff G., Comfort M., Kobayashi G. S. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med. 1971 Nov;138(2):571–574. doi: 10.3181/00379727-138-35943. [DOI] [PubMed] [Google Scholar]
  20. Newmark E., Ellison A. C., Kaufman H. E. Pimaricin therapy of cephalosporium and fusarium keratitis. Am J Ophthalmol. 1970 Mar;69(3):458–466. doi: 10.1016/0002-9394(70)92283-x. [DOI] [PubMed] [Google Scholar]
  21. Normark S., Schönebeck J. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata. Antimicrob Agents Chemother. 1972 Sep;2(3):114–121. doi: 10.1128/aac.2.3.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Plempel M., Bartmann K., Büchel K. H., Regel E. BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity. Antimicrob Agents Chemother (Bethesda) 1969;9:271–274. [PubMed] [Google Scholar]
  23. Richards A. B., Clayton Y. M., Jones B. R. Antifungal drugs for oculomycosis. IV. The evaluation of antifungal drugs in the living animal cornea. Trans Ophthalmol Soc U K. 1970;89:847–861. [PubMed] [Google Scholar]
  24. Richards A. B., Jones B. R., Whitwell J., Clayton Y. M. Corneal and intra-ocular infection by Candida albicans treated with 5-fluorocytosine. Trans Ophthalmol Soc U K. 1970;89:867–885. [PubMed] [Google Scholar]
  25. Rocklin R. E., Chilgren R. A., Hong R., David J. R. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol. 1970 Sep;1(3):290–299. doi: 10.1016/0008-8749(70)90050-x. [DOI] [PubMed] [Google Scholar]
  26. SELIGMANN E. Virulence enhancing activities of aureomycin on Candida albicans. Proc Soc Exp Biol Med. 1952 Mar;79(3):481–484. doi: 10.3181/00379727-79-19418. [DOI] [PubMed] [Google Scholar]
  27. Schlosser E., Gottlieb D. Sterols and the sensitivity of Pythium species to filipin. J Bacteriol. 1966 Mar;91(3):1080–1084. doi: 10.1128/jb.91.3.1080-1084.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schulking M. L., Adler W. H., 3rd, Altemeier W. A., 3rd, Ayoub E. M. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol. 1972 Apr;3(4):606–615. doi: 10.1016/0008-8749(72)90122-0. [DOI] [PubMed] [Google Scholar]
  29. Shadomy S. Further in vitro studies with 5-fluorocytosine. Infect Immun. 1970 Oct;2(4):484–488. doi: 10.1128/iai.2.4.484-488.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shadomy S. In vivo studies with Bay b 5097. Antimicrob Agents Chemother (Bethesda) 1970;10:169–174. [PubMed] [Google Scholar]
  31. Steer P. L., Marks M. I., Klite P. D., Eickhoff T. C. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med. 1972 Jan;76(1):15–22. doi: 10.7326/0003-4819-76-1-15. [DOI] [PubMed] [Google Scholar]
  32. VANWINKLE M. G., RHEINS M. S., SUIE T. EFFECTS OF ANTIBIOTICS ON EXPERIMENTAL CANDIDA CORNEAL INFECTIONS. Am J Ophthalmol. 1964 Jan;57:84–87. doi: 10.1016/0002-9394(64)92035-5. [DOI] [PubMed] [Google Scholar]
  33. Vandevelde A. G., Mauceri A. A., Johnson J. E., 3rd 5-fluorocytosine in the treatment of mycotic infections. Ann Intern Med. 1972 Jul;77(1):43–51. doi: 10.7326/0003-4819-77-1-43. [DOI] [PubMed] [Google Scholar]
  34. Waitz J. A., Moss E. L., Weinstein M. J. Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole). Appl Microbiol. 1971 Nov;22(5):891–898. doi: 10.1128/am.22.5.891-898.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wong V. G., Kirkpatrick C. H. Immunologic reconstitution in a patient with keratoconjunctivitis, superficial candidiasis and hypoparathyroidism: the role of immunocompetent lymphocyte transfusion and transfer factor. Trans Am Ophthalmol Soc. 1973;71:254–271. [PMC free article] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES